Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

Tanddyreklinikken ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5%   Bankruptcy risk   1.8% 1.8% 4.3% 1.8% 1.5% 2.1% 13.8% 13.8%   Credit score (0-100)   74 72 47 71 75 66 16 16   Credit rating   A A BBB A A BBB BB BB   Credit limit (kDKK)   1.2 1.0 0.0 2.8 15.7 0.3 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   1,852 3,623 5,003 8,126 7,245 7,651 0.0 0.0   EBITDA   917 711 709 2,792 1,810 2,829 0.0 0.0   EBIT   897 409 38.5 2,000 1,165 2,433 0.0 0.0   Pre-tax profit (PTP)   894.6 401.0 3.6 1,959.7 1,148.5 2,424.0 0.0 0.0   Net earnings   701.6 304.8 -0.6 1,523.9 888.4 1,882.5 0.0 0.0   Pre-tax profit without non-rec. items   895 401 3.6 1,960 1,148 2,424 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   710 1,652 1,962 1,337 1,187 811 0.0 0.0   Shareholders equity total   752 1,024 1,024 1,598 1,536 2,019 68.5 68.5   Interest-bearing liabilities   174 1,100 1,192 35.7 137 315 22.5 22.5   Balance sheet total (assets)   1,483 3,373 6,153 3,465 4,355 3,677 91.0 91.0   Net Debt   -375 -160 -1,558 -453 -1,896 -1,708 22.5 22.5     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   1,852 3,623 5,003 8,126 7,245 7,651 0.0 0.0   Gross profit growth   0.0% 95.6% 38.1% 62.4% -10.8% 5.6% -100.0% 0.0%   Employees   2 6 6 8 8 8 0 0   Employee growth %   0.0% 200.0% 0.0% 33.3% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   1,483 3,373 6,153 3,465 4,355 3,677 91 91   Balance sheet change%   0.0% 127.5% 82.4% -43.7% 25.7% -15.6% -97.5% 0.0%   Added value   916.9 711.1 709.4 2,791.6 1,957.2 2,828.9 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   690 809 -381 -1,436 -814 -792 -811 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   1.0 2.0 3.0 4.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   48.4% 11.3% 0.8% 24.6% 16.1% 31.8% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   60.5% 16.8% 0.8% 41.6% 29.8% 60.6% 0.0% 0.0%   ROI %   94.9% 25.8% 1.7% 101.5% 70.2% 121.5% 0.0% 0.0%   ROE %   93.3% 34.3% -0.1% 116.3% 56.7% 105.9% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   50.7% 30.4% 16.6% 46.1% 35.3% 54.9% 75.3% 75.3%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -40.9% -22.5% -219.6% -16.2% -104.7% -60.4% 0.0% 0.0%   Gearing %   23.2% 107.4% 116.4% 2.2% 8.9% 15.6% 32.8% 32.8%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   2.4% 1.2% 3.0% 6.5% 19.6% 4.0% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   0.9 0.6 0.8 0.9 0.9 1.5 0.0 0.0   Current Ratio   1.1 0.7 0.8 1.1 1.1 1.7 0.0 0.0   Cash and cash equivalent   549.5 1,260.6 2,750.3 488.6 2,032.7 2,022.7 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   60.7 -700.6 -1,010.2 144.1 238.6 1,117.0 -11.2 -11.2   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   458 119 118 349 245 354 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   458 119 118 349 226 354 0 0   EBIT / employee   448 68 6 250 146 304 0 0   Net earnings / employee   351 51 -0 190 111 235 0 0